BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16149621)

  • 21. [Carcinoembryonic antigen (CEA)].
    Kinugasa T; Kuroki M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():632-4. PubMed ID: 16149597
    [No Abstract]   [Full Text] [Related]  

  • 22. Nervous system-specific enolase in serum as a marker for neuroblastoma.
    Ishiguro Y; Kato K; Ito T; Nagaya M; Yamada N; Sugito T
    Pediatrics; 1983 Nov; 72(5):696-700. PubMed ID: 6356007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A clinical study on neuron specific enolase (NSE) as a tumor marker in primary lung cancer].
    Suzuki K; Reshad K; Takahashi Y; Morita H; Hirata T; Itoi K; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jun; 25(6):625-31. PubMed ID: 2824900
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical value of neuron specific enolase and tissue polipeptidic antigen for the management of patients with lung cancer.
    Spinazzi A; Soresi E; Borghini U; Boffi R; Vigorelli R; Scoccia S
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):141-5. PubMed ID: 1965446
    [No Abstract]   [Full Text] [Related]  

  • 25. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
    Kannagi R; Izawa M; Koike T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
    [No Abstract]   [Full Text] [Related]  

  • 26. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
    Eberlein-Gonska M; Wiedenmann B; Waldherr R
    Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determining the level of the tumor marker--neuron-specific enolase in patients with neoplastic and non-neoplastic diseases].
    Romanova LF; Khaĭlenko VA; Kuznetsova LF; Davydov MI; Komov DV; Kulish VL; Platinskiĭ LV; Poddubskaia EV
    Klin Med (Mosk); 1991 Sep; 69(9):38-9. PubMed ID: 1803146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of neuron-specific enolase (NSE) in the diagnosis of bronchial carcinomas and neuroendocrine tumors].
    Fischbach W; Jany B; Nelkenstock R
    Dtsch Med Wochenschr; 1986 Nov; 111(45):1721-5. PubMed ID: 3023003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
    Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
    In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuron specific enolase in small cell lung cancer].
    Lee HJ; Chiang CD; Yiih KT; Huang WL; Jih KS; Lin TM; Chung WC; Sheu JY; Wang SJ
    Taiwan Yi Xue Hui Za Zhi; 1988 Apr; 87(4):465-71. PubMed ID: 2852705
    [No Abstract]   [Full Text] [Related]  

  • 31. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuron-specific enolase: a new marker for small-cell pulmonary carcinoma].
    Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Oliaro A; Pischedda F; Ardissone F
    Minerva Med; 1987 Apr; 78(7):465-7. PubMed ID: 3033550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
    Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
    Anticancer Res; 1989; 9(6):1717-20. PubMed ID: 2560624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [KMO1].
    Kamigaki T; Kuroda Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():691-3. PubMed ID: 16149613
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuron-specific enolase--a selective marker of small cell bronchial cancer].
    Lorenz J; Mai GA; Schulz V
    Prax Klin Pneumol; 1986 Mar; 40(3):100-2. PubMed ID: 3012500
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuron specific enolase].
    Odagiri E
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():759-61. PubMed ID: 20960866
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase].
    Maruno K
    Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):760-5. PubMed ID: 2169019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CA19-9].
    Odagiri E
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():642-4. PubMed ID: 16149600
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
    Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
    Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.